Single-port endoscopic breast-conserving surgery for early breast cancer

doi:10.3877/cma.j.issn.1674-0807.2020.04.006

Abstract

Abstract:

Objective

To explore the application of the single-port endoscopic breast-conserving surgery in the treatment of early breast cancer.

Methods

The clinical data of 102 patients with stage I and II breast cancer who underwent breast-conserving surgery in the Beijing Friendship Hospital, Capital Medical University from May 2017 to November 2018 were retrospectively analyzed. Among them, 48 patients underwent single-port endoscopic breast-conserving surgery (endoscopic surgery group) and 54 patients received open breast-conserving surgery (open surgery group). The operative time, cosmetic effect, complications and recurrence were assessed. The t test of two independent samples was used to compare the operation time and cosmetic effect between the two groups.

Results

All 102 patients had successfully completed the surgery. The operative time in the endoscopic surgery group was (184.2 ±76.2) min, significantly longer than (127.8 ±68.4) min in the open surgery group (t=3.923, P<0.001). The cosmetic evaluation at postoperative two months showed that the score of cosmetic effect in the endoscopic surgery group was significantly higher than that in the open surgery group (11.2±0.8 vs 9.1±0.9, t=6.407, P<0.001). There was no skin necrosis, active bleeding and infection in both groups. The median follow-up was 11.2 months. There was no local recurrence or distant metastasis in both groups.

Conclusion

The single-port endoscopic breast-conserving surgery can guarantee the radical resection of early breast cancer, and obtain better cosmetic effect compared with open breast-conserving surgery.

Key words: Breast neoplasms, Endoscopy, Mastectomy

Zihan Wang, Fang Xie, Xiaosheng Yan, Zhongtao Zhang, Shanshan Wu, Hairui Wu, Xiang Qu. Single-port endoscopic breast-conserving surgery for early breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2020, 14(04): 228-233.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2020.04.006

https://zhrxbzz.cma-cmc.com.cn/EN/Y2020/V14/I04/228

Figures/Tables 6

References 21

[1]	Botteri E, Veronesi P, Vila J, et al. Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery[J]. Br J Surg, 2017，104(13): 1802-1810.
[2]	Van Maaren MC, De Munck L, De Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study[J]. Lancet Oncol, 2016, 17(8): 1158-1170.
[3]	Zhao S, Liu Y, Huang F, et al. The long-term outcome of adjuvant hypofractionated radiotherapy and conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer：a prospective analysis of 107 cases[J]．J Thorac Dis, 2017, 9(10): 3840-3850.
[4]	王子函，王岳月，滕长胜，等．单孔悬吊法腔镜保乳手术与开放保乳手术在早期乳腺癌治疗中的对照研究[J]．临床和实验医学杂志，2016，15(13): 1306-1310.
[5]	张慧明，伍海锐，王子函，等. 腔镜保乳手术联合射频消融术治疗早期乳腺癌的临床研究[J]．国际外科学杂志，2017，44(6): 392-396.
[6]	de Kock I, Mirhosseini M, Lau F, et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools[J]. J Palliat Care, 2013，29(3): 163-169.
[7]	Yamashita K. Cosmetic assessment[J]. J Jpn Soc Endosc Surg, 2005，10(2): 165-170.
[8]	孙可欣，郑荣寿，顾秀瑛，等.2000—2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析[J]．中华预防医学杂志，2018, 52(6): 567-572.
[9]	Aerts L, Christiaens MR, Enzlin P, et al. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study[J]. Breast, 2014，23(5): 629-636.
[10]	Christiansen P, Carstensen SL, Ejlertsen B, et al.Breast conserving surgery versus mastectomy：overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG) [J]．Acta Oncol, 2018, 57 (1): 19-25.
[11]	刘婷，韩宝三．乳腺癌保乳整复手术：根治与保乳的平衡[J]．上海医药，2018，39(19): 15-19.
[12]	黄欣，陈畅，周易冬，等．乳腺导管原位癌保留乳房手术后序贯放射治疗的研究进展[J/CD]．中华乳腺病杂志(电子版)，2018，12(1): 50-54.
[13]	Vila J, Gandini S, Gentilini O. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy[J]. Breast, 2015，24(3): 175-181.
[14]	Milone M, Elmore U, Musella M, et al. Safety and efficacy of laparoscopic wedge gastrectomy for large gastrointestinal stromal tumors[J]．Eur J Surg Oncol, 2017, 43 (4): 796-800.
[15]	Ha TY, Yoon YI, Hwang S，et al. Effect of reoperation on long term outcome of pT1b/T2 gallbladder carcinoma after initial laparoscopic cholecystectomy[J]．J Gastrointest Surgy，2015，19(2): 298-305.
[16]	王子函，张玉龙，王捷，等．保留乳头乳晕的单孔法腔镜皮下乳腺切除术治疗早期乳腺癌的临床疗效[J]．腹腔镜外科杂志，2018，23(3): 188-193.
[17]	胡俊丰，李明，胡超，等．乳腔镜乳房皮下腺体切除术治疗男子乳腺发育17例[J]．中国微创外科杂志，2019，19(1): 15-18.
[18]	姜军. 乳腺疾病腔镜治疗[M]．北京：人民卫生出版社，2012：4-12.
[19]	Wang ZH, Qu X, Teng CS, et al. Preliminary results for treatment of early stage breast cancer with endoscopic subcutaneous mastectomy combined with endoscopic sentinel lymph node biopsy in China[J]. J Surg Oncol，2016, 113(6): 616-620.
[20]	骆成玉. 微创与功能——乳腺外科"加减法" [J/CD]．中华腔镜外科杂志(电子版)，2018，11(4): 199-202.
[21]	刘嘉琦，何贵金．乳腔镜下腋窝淋巴结清扫术与常规腋窝淋巴结清扫术术后恢复及并发症的临床比较[J/CD]．中华乳腺病杂志(电子版)，2017，11(4): 218-222.

组别	例数	年龄(岁)	肿瘤最大径(cm)	病变部位[例(%)]		TNM分期[例(%)]		相关受体[例(%)]
组别	例数	年龄(岁)	肿瘤最大径(cm)	左乳	右乳	Ⅰ期	Ⅱ期	ER(＋)	PR(＋)	HER-2(＋)
腔镜组	48	53.1±8.8	1.7±0.6	25(52.1)	23(47.9)	28(58.3)	20(42.7)	35(72.9)	33(68.8)	19(39.6)
开放组	54	54.5±10.5	2.0±0.7	29(53.7)	25(46.3)	38(70.3)	16(29.7)	37(68.5)	30(55.6)	22(40.8)
检验值		t＝-0.715	t＝-1.822	χ²＝0.027		χ²＝1.612		χ²＝0.237	χ²＝1.873	χ²＝0.014
P值		0.476	0.071	0.870		0.204		0.627	0.171	0.905

组别	例数	年龄(岁)	肿瘤最大径(cm)	病变部位[例(%)]		TNM分期[例(%)]		相关受体[例(%)]
组别	例数	年龄(岁)	肿瘤最大径(cm)	左乳	右乳	Ⅰ期	Ⅱ期	ER(＋)	PR(＋)	HER-2(＋)
腔镜组	48	53.1±8.8	1.7±0.6	25(52.1)	23(47.9)	28(58.3)	20(42.7)	35(72.9)	33(68.8)	19(39.6)
开放组	54	54.5±10.5	2.0±0.7	29(53.7)	25(46.3)	38(70.3)	16(29.7)	37(68.5)	30(55.6)	22(40.8)
检验值		t＝-0.715	t＝-1.822	χ²＝0.027		χ²＝1.612		χ²＝0.237	χ²＝1.873	χ²＝0.014
P值		0.476	0.071	0.870		0.204		0.627	0.171	0.905

组别	例数	手术时间(min)	切口长度(cm)	术中出血量[ml，M(P₂₅～P₇₅)]	总引流量[ml，M(P₂₅～P₇₅)]	引流管留置[d，M(P₂₅～P₇₅)]	住院时间(d)	美容效果(分)
腔镜组	48	184.2±76.2	3.3±1.1	20(10.0～40.0)	102.5(60.0～171.5)	5(3，6)	11.1±3.8	11.2±0.8
开放组	54	127.8±68.4	5.8±2.6	20(10.0～22.5)	65.2(37.0～44.5)	5(4，6)	10.1±3.1	9.1±0.9
检验值		t＝3.923	t＝-6.321	Z＝-0.465	Z＝-2.091	Z＝1.139	t＝1.480	t＝6.407
P值		<0.001	<0.001	0.624	0.073	0.255	0.142	<0.001

组别	例数	手术时间(min)	切口长度(cm)	术中出血量[ml，M(P₂₅～P₇₅)]	总引流量[ml，M(P₂₅～P₇₅)]	引流管留置[d，M(P₂₅～P₇₅)]	住院时间(d)	美容效果(分)
腔镜组	48	184.2±76.2	3.3±1.1	20(10.0～40.0)	102.5(60.0～171.5)	5(3，6)	11.1±3.8	11.2±0.8
开放组	54	127.8±68.4	5.8±2.6	20(10.0～22.5)	65.2(37.0～44.5)	5(4，6)	10.1±3.1	9.1±0.9
检验值		t＝3.923	t＝-6.321	Z＝-0.465	Z＝-2.091	Z＝1.139	t＝1.480	t＝6.407
P值		<0.001	<0.001	0.624	0.073	0.255	0.142	<0.001

Please choose a citation manager

Content to export